AUD 0.04
(5.88%)
Year | Total Debt | Total Debt Growth |
---|---|---|
2024 | - USD | -17.63% |
2023 | 9.78 Million USD | 36.02% |
2022 | 7.19 Million USD | -0.04% |
2021 | 7.19 Million USD | 121.88% |
2020 | 3.24 Million USD | -68.89% |
2019 | 10.42 Million USD | 103.12% |
2018 | 5.13 Million USD | 0.0% |
Year | Total Debt | Total Debt Growth |
---|---|---|
2024 Q1 | 7.62 Million USD | 5.94% |
2024 Q2 | 7.62 Million USD | 0.0% |
2024 Q3 | - USD | -100.0% |
2024 Q4 | - USD | 0.0% |
2023 Q2 | 4.23 Million USD | 0.0% |
2023 FY | 9.78 Million USD | 36.02% |
2023 Q1 | 4.23 Million USD | -41.1% |
2023 Q4 | 7.19 Million USD | -20.88% |
2023 Q3 | 9.09 Million USD | 114.61% |
2022 Q3 | 6.22 Million USD | -12.09% |
2022 Q1 | 7.08 Million USD | -1.6% |
2022 Q2 | 7.08 Million USD | 0.0% |
2022 FY | 7.19 Million USD | -0.04% |
2022 Q4 | 7.19 Million USD | 15.55% |
2021 Q1 | 21 Million USD | 547.55% |
2021 FY | 7.19 Million USD | 121.88% |
2021 Q4 | 7.19 Million USD | 0.0% |
2021 Q3 | 7.19 Million USD | -68.16% |
2021 Q2 | 22.6 Million USD | 7.62% |
2020 FY | 3.24 Million USD | -68.89% |
2020 Q3 | 2.89 Million USD | 0.0% |
2020 Q1 | - USD | 0.0% |
2020 Q4 | 3.24 Million USD | 12.22% |
2019 FY | 10.42 Million USD | 103.12% |
2018 FY | 5.13 Million USD | 0.0% |
Name | Total Debt | Total Debt Difference |
---|---|---|
Australian Clinical Labs Limited | 308.89 Million AUD | 100.0% |
BCAL Diagnostics Limited | 641.34 Thousand AUD | 100.0% |
Genetic Signatures Limited | 1.22 Million AUD | 100.0% |
Genetic Technologies Limited | 643.54 Thousand AUD | 100.0% |
Healius Limited | 1.59 Billion AUD | 100.0% |
Imagion Biosystems Limited | 6.03 Million AUD | 100.0% |
Integral Diagnostics Limited | 357.79 Million AUD | 100.0% |
INOVIQ Ltd | 535.05 Thousand AUD | 100.0% |
Microba Life Sciences Limited | 395.38 Thousand AUD | 100.0% |
Monash IVF Group Limited | 59.56 Million AUD | 100.0% |
Rhythm Biosciences Limited | 163.82 Thousand AUD | 100.0% |
Sonic Healthcare Limited | 4.51 Billion AUD | 100.0% |